A novel and significant finding in the present study was the identification that AA-induced upregulation of hepatic Smad7, thereby inhibiting TGF-beta/Smad signaling, was a mechanism by which AA inhibits CCl4 or TGF-beta1-induced HSC activation and liver fibrosis in vivo and in vitro. Here, SMAD7 is linked to Hepatic fibrosis.